
CERULISIN * GTT OTO FL 20ML
- IBSA FARMACEUTICI ITALIA Srl
-
020157018
Ear drops indicated for the removal of ear wax.
Even with a credit card
FREE in Italy over € 39.90
14 days to reconsider
Always at your service
Ear drops indicated for the removal of ear wax.
Even with a credit card
FREE in Italy over € 39.90
14 days to reconsider
Always at your service
IBSA FARMACEUTICI ITALIA Srl
Discover all productsCERULISIN * GTT OTO FL 20ML
For the dissolution of earwax and epidermal plugs. In dressing for cleaning operating cavities following interventions in the middle ear.
Posology The usual dose is equal to the contents of the dropper. For hard caps, the instillations are performed 2-3 times a day and the treatment must be continued for 3-5 days in relation to the amount of ear wax to be extracted. Do not exceed the recommended dose. Method of administration Topical use. The contents of a dropper, preferably warmed, is poured, after tilting the head, into the ear canal. The subject should remain in this position for 5-10 minutes. Afterwards, the ear is washed with warm water.
§ Hypersensitivity to the active ingredients. § Middle ear diseases (otitis, perforated eardrum).
Prolonged use of CERULISIN can cause sensitization phenomena. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit / risk ratio of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.aifa.gov.it/content/segnalazioni-reazioni-avverse .
The use of the medicine does not involve special precautions. Do not use in cases of perforated eardrum. The use, especially if prolonged, of the medicine can give rise to sensitization phenomena. If this occurs, discontinue treatment and institute appropriate therapy. Do not use the medicine after the expiry date indicated on the package. Report the onset of any undesirable effects not described in the package leaflet, see section 4.8.
There are no known harmful effects at normal therapeutic doses.
None.
There are no known interactions between CERULISIN and other drugs.
No cases of overdose have been reported.
1 ml contains: • active ingredients: dimethylbenzene 46 mg, sweet almond oil 870 mg.
Not present